Oragenics, Inc. (OGEN)
0.5399
+0.02
(+3.81%)
USD |
NYAM |
Aug 26, 12:16
Oragenics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.0091 |
| December 31, 2025 | 0.0274 |
| September 30, 2025 | 0.0402 |
| June 30, 2025 | -1.41 |
| March 31, 2025 | 18.55 |
| December 31, 2024 | -1.550 |
| September 30, 2024 | 0.1688 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.0483 |
| December 31, 2023 | 0.1018 |
| September 30, 2023 | 0.0797 |
| June 30, 2023 | 0.0353 |
| March 31, 2023 | 0.0405 |
| December 31, 2022 | 0.048 |
| September 30, 2022 | 0.0544 |
| June 30, 2022 | 0.0237 |
| March 31, 2022 | 0.0259 |
| December 31, 2021 | 0.0301 |
| September 30, 2021 | 0.0358 |
| June 30, 2021 | 0.0178 |
| March 31, 2021 | 0.0206 |
| December 31, 2020 | 0.0534 |
| September 30, 2020 | 0.1229 |
| June 30, 2020 | 0.1009 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0671 |
| December 31, 2019 | 0.0568 |
| September 30, 2019 | 0.0451 |
| June 30, 2019 | 0.0315 |
| March 31, 2019 | 0.0072 |
| December 31, 2018 | 0.0059 |
| September 30, 2018 | 0.0136 |
| June 30, 2018 | 0.0057 |
| March 31, 2018 | 0.0157 |
| December 31, 2017 | 0.0127 |
| September 30, 2017 | 2.496 |
| June 30, 2017 | 4.792 |
| March 31, 2017 | 0.053 |
| December 31, 2016 | 0.0222 |
| September 30, 2016 | 0.0203 |
| June 30, 2016 | 0.0048 |
| March 31, 2016 | 0.0274 |
| December 31, 2015 | 0.0134 |
| September 30, 2015 | 3.399 |
| June 30, 2015 | 1.627 |
| March 31, 2015 | 0.0087 |
| December 31, 2014 | 0.0063 |
| September 30, 2014 | 0.0095 |
| June 30, 2014 | 0.0029 |
| March 31, 2014 | 0.0057 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 5.492M |
| Total Liabilities (Quarterly) | 1.822M |
| Shareholders Equity (Quarterly) | 3.671M |
| Current Ratio | 3.015 |
| Net Debt Paydown Yield | 19.50% |